Abstract
Simpotentin, a new potentiator of amphotericin B activity against Candida albicans and Cryptococcus neoformans, was isolated from the culture broth of Simplicillium minatense FKI-4981 by Diaion HP-20 column chromatography, centrifugal partition chromatography, and preparative HPLC. The structure of simpotentin was elucidated by spectroscopic analyses including NMR and MS. The compound has a mannose core to which two medium-chain fatty acids are linked. Simpotentin was found to potentiate amphotericin B activity against C. albicans by the microdilution method.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Taxonomic and phylogenetic characterizations reveal four new species of Simplicillium (Cordycipitaceae, Hypocreales) from Guizhou, China
Scientific Reports Open Access 27 July 2021
-
Synergistic antifungal interactions of amphotericin B with 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol
Scientific Reports Open Access 10 September 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis. 2006;43(Suppl 1):S3–S14.
Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE, NIAID Mycoses Study Group. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003;37:634–43.
Oura M, Sternberg TH, Wright ET. A new antifungal antibiotic, amphotericin B. Antibiot Annu. 1956;3:566–73.
Ishijima H, Uchida R, Ohtawa M, Kondo A, Nagai K, Shima K, Nonaka K, Masuma R, Iwamoto S, Onodera H, Nagamitsu T, Tomoda H. Simplifungin and valsafungins, antifungal antibiotics of fungal origin. J Org Chem. 2016;81:7373–83.
Bock K, Lundt I, Pedersen C. Assignment of anomer structure to carbohydrates through geminal 13C-1H coupling constants. Tetrahedron Lett. 1973;13:1037–40.
Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. CLSI document M27-A3. 3rd edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
Gams W, Zare R. A revision of Verticillium sect. Prostrata. III. Generic Classif Nova Hedwig. 2001;72:329–37.
McCorkindale NJ, Hutchinson SA, McRitchie AC, Sood GR. Lamellicolic anhydride, 4-O-carbomethoxylamellicolic anhydride and monomethyl 3-chlorolamellicolate, metabolites of Verticillium lamellicola. Tetrahedron. 1983;39:2283–8.
Rowin GL, Miller JE, Albers-Schönberg G, Onishi JC, Davis D, Dulaney EL. Verlamelin, a new antifungal agent. J Antibiot. 1986;39:1772–5.
Takata K, Iwatsuki M, Yamamoto T, Shirahata T, Nonaka K, Masuma R, Hayakawa Y, Hanaki H, Kobayashi Y, Petersson GA, Ōmura S, Shiomi K. Aogacillins A and B produced by Simplicillium sp. FKI-5985: new circumventors of arbekacin resistance in MRSA. Org Lett. 2013;15:4678–81.
Itoh S, Honda H, Tomita F, Suzuki T. Rhamnolipids produced by Pseudomonas aeruginosa grown on n-paraffin. J Antibiot. 1971;24:855–9.
Haba E, Pinazo A, Jauregui O, Espuny MJ, Infante MR, Manresa A. Physicochemical characterization and antimicrobial properties of rhamnolipids produced by Pseudomonas aeruginosa 47T2 NCBIM 40044. Biotechnol Bioeng. 2003;81:316–22.
Dobler L, Vilela LF, Almeida RV, Neves BC. Rhamnolipids in perspective: gene regulatory pathways, metabolic engineering, production and technological forecasting. N Biotechnol. 2016;33:123–35.
Stanghellini ME, Miller RM. Biosurfactants: Their identity and potential efficacy in the biological control of zoosporic plant pathogens. Plant Dis. 1997;81:4–12.
Kristoffersen V, Rämä T, Isaksson J, Andersen JH, Gerwick WH, Hansen E. Characterization of rhamnolipids produced by an arctic marine bacterium from the pseudomonas fluorescence group. Mar Drugs. 2018;16:E163.
Sorensen KN, Kim KH, Takemoto JY. In vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae. Antimicrob Agents Chemother. 1996;40:2710–3.
Takemoto JY, Bensaci M, De Lucca AJ, Cleveland TE, Gandhi NR, Skebba VP. Inhibition of fungi from diseased grape by syringomycin E-rhamnolipid mixture. Am J Enol Vitic. 2010;61:120–4.
Takemoto, JY, Brand JG, Kaulin YA, Malex, VV, Schabina LV, Blasko, K. The syringomycins: lipodepsipeptide pore formers from plant bacterium. In: Menestrina, G, Serra MD & Lazarovic, P, editors. Pore forming peptides and protein toxins. London: Taylor & Francis; 2003. p. 260–71.
Le Dang Q, Shin TS, Park MS, Choi YH, Choi GJ, Jang KS, Kim IS, Kim JC. Antimicrobial activities of novel mannosyl lipids isolated from the biocontrol fungus Simplicillium lamellicola BCP against phytopathogenic bacteria. J Agric Food Chem. 2014;62:3363–70.
Nonaka K, Kaifuchi S, Ōmura S, Masuma R. Five new Simplicillium species (Cordycipitaceae) from soils in Tokyo, Japan. Mycoscience. 2012;54:42–53.
Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A2. 3rd edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
Koyama N, Nagahiro T, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S. Stemphones, novel potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Aspergillus sp. FKI-2136. J Antibiot. 2005;58:695–703.
Kaneko M, Matsuda D, Ohtawa M, Fukuda T, Nagamitsu T, Yamori T, Tomoda H. Potentiation of bleomycin in Jurkat cells by fungal pycnidione. Biol Pharm Bull. 2012;35:18–28.
Acknowledgements
We express our thanks to Dr. Kenichiro Nagai and Ms. Noriko Sato of the School of Pharmacy, Kitasato University for the measurements of NMR and mass spectra. This work was supported by JSPS KAKENHI Grant Numbers 16H05095 (to RU) and 21310146 (to HT).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Uchida, R., Kondo, A., Yagi, A. et al. Simpotentin, a new potentiator of amphotericin B activity against Candida albicans, produced by Simplicillium minatense FKI-4981. J Antibiot 72, 134–140 (2019). https://doi.org/10.1038/s41429-018-0128-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-018-0128-x
This article is cited by
-
New potentiators of amphotericin B activity, shodoamides A to C produced by Pseudophialophora sp. BF-0158
The Journal of Antibiotics (2023)
-
New piericidin rhamnosides as potentiators of amphotericin B activity against Candida albicans produced by actinomycete strain TMPU-A0287
The Journal of Antibiotics (2023)
-
Taxonomic and phylogenetic characterizations reveal four new species of Simplicillium (Cordycipitaceae, Hypocreales) from Guizhou, China
Scientific Reports (2021)
-
Podogigants A and B, two new potentiators of amphotericin B activity, from Sordariomycete Podostroma giganteum
Journal of Natural Medicines (2021)
-
Polyketide glycosides phialotides A to H, new potentiators of amphotericin B activity, produced by Pseudophialophora sp. BF-0158
The Journal of Antibiotics (2020)